<oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>Single Incision Device (TVT Secur) Versus Retropubic Tension-free Vaginal Tape Device (TVT) for the Management of Stress Urinary Incontinence in Women: A Randomized Clinical Trial</dc:title><dc:identifier>https://doi.org/10.7939/DVN/10962</dc:identifier><dc:creator>Ross, Sue</dc:creator><dc:creator>Tang, Selphee</dc:creator><dc:creator>Schulz, Jane</dc:creator><dc:creator>Murphy, Magnus</dc:creator><dc:creator>Goncalves, Jose</dc:creator><dc:creator>Kaye, Stephen</dc:creator><dc:creator>Dederer, Lorel</dc:creator><dc:creator>Robert, Magali</dc:creator><dc:publisher>UAL Dataverse</dc:publisher><dc:description>The objective of this Canadian multi-centre pragmatic randomized controlled trial was to compare the effectiveness of the new single-incision device, Gynecare TVT Secur, to the established predecate retropubic TVT device, in terms of objective cure of stress urinary incontinence (SUI) at 12 months postoperatively. Other outcomes included: complications, symptoms, and incontinence-related quality of life.</dc:description><dc:subject>Medicine, Health and Life Sciences</dc:subject><dc:subject>single incision device</dc:subject><dc:subject>stress urinary incontinence</dc:subject><dc:subject>surgical treatment</dc:subject><dc:subject>effectiveness</dc:subject><dc:subject>randomized controlled trial</dc:subject><dc:date>2008</dc:date><dc:type>Questionnaire data; Clinical data</dc:type><dc:source>Urogenital Distress Inventory (UDI-6); Incontinence Impact Questionnaire (IIQ-7); the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire-12, (PISQ-12); the 15D Instrument of Health-related Quality of Life (15D) was included for the proposed economic evaluation which was never done.</dc:source></oai_dc:dc>